🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-18
Trial ID
NCT06878833
Treatments Being Tested
The purpose of this study is to investigate whether Risperidone is effectiv...
Status
Unknown
Location
Hospital de Clinicas de Porto Alegre
Start Date
2009-01
Trial ID
NCT00825552
Treatments Being Tested
Objective: * To assess the bioequivalence of Risperidone 1.0 mg tablets of...
Status
Completed
Location
Lotus Labs Pvt. Ltd.
Start Date
TBD
Trial ID
NCT00939926
Treatments Being Tested
This is an open-label, one sequence study to evaluate the steady-state comp...
Status
Completed
Location
Collaborative Neuroscience Network
Start Date
2018-07-09
Trial ID
NCT03527186
Treatments Being Tested
SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06060886
Treatments Being Tested
The purpose of this trial is to investigate the efficacy of risperidone as ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2004-06
Trial ID
NCT00167154
Treatments Being Tested
The purpose of this research of 400 participants is to determine whether a ...
Status
Completed
Location
VA Medical Center, Tuscaloosa
Start Date
2006-10
Trial ID
NCT00099983
Treatments Being Tested
An inpatient/outpatient study to see if LY2140023 is better than placebo in...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-03
Trial ID
NCT01086748
Treatments Being Tested
This trial examines the efficacy of cannabidiol (CBD) versus risperidone fo...
Status
Active Not Recruiting
Location
Center for Neuropsychiatric Schizophrenia Research
Start Date
2021-06-01
Trial ID
NCT04105231
Treatments Being Tested
This 16-week placebo-control study looks to investigate whether patients wi...
Status
Completed
Location
The Zucker Hillside Hospital
Start Date
2013-05
Trial ID
NCT01786239
Treatments Being Tested